DRCNet Response to the
Drug Enforcement Administration
DRCNet Response to the
Drug Enforcement Administration
| Drug:: | Fentanyl & Analogs |
| Classification:: | Narcotic |
| CSA Schedule: | Schedule I, II |
| Trade or Other Names: | Innovar; Sublimaze; Alfenta; Sufenta; Duragesic |
| Medical Uses: | Analgesic; Adjunct to anesthesia; Anesthetic |
| Physical Dependence: | High |
| Psychological Dependence: | High |
| Tolerance: | Yes |
| Duration (hours): | 10-72 |
| Usual Method: | Injected; Transdermal patch |
| Possible Effects: | Euphoria; Drowsiness; Respiratory depression; Constricted pupils; Nausea |
| Effects of Overdose: | Slow and shallow breathing; Clammy skin; Convulsions; Coma; Possible death |
| Withdrawal Syndrome: | Watery eyes; Runny nose; Yawning; Loss of appetite; Irritability; Tremors; Panic; Cramps; Nausea; Chills & sweating |
Travel back to the DRCNet Response to the DEA Home Page
Travel back to the Drug Chart List
Travel back to the Use & Effects List